George Dangas

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi request reprint Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial)
    George Dangas
    Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY, USA
    Am Heart J 155:1090-6. 2008
  2. doi request reprint Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial)
    Kenichi Tsujita
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 105:1385-94. 2010
  3. doi request reprint Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial)
    Kenji Goto
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 108:1387-94. 2011
  4. ncbi request reprint Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model
    Nicholas N Kipshidze
    Department of Interventional Cardiac and Vascular Services, Lenox Hill Hospital, New York, NY 10021, USA
    Catheter Cardiovasc Interv 64:389-94. 2005
  5. doi request reprint Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial
    Gregg W Stone
    New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10022, USA
    Lancet 377:2193-204. 2011
  6. ncbi request reprint Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model
    Nicholas N Kipshidze
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
    Catheter Cardiovasc Interv 61:518-27. 2004
  7. doi request reprint Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes
    Usman Baber
    Mount Sinai Medical Center, New York, New York, USA
    JACC Cardiovasc Imaging 5:S53-61. 2012
  8. doi request reprint Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial
    George Dangas
    Columbia University Medical Center, New York, New York Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 54:1438-46. 2009
  9. doi request reprint Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction
    Gregg W Stone
    Columbia University Medical Center and New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 360:1946-59. 2009
  10. ncbi request reprint Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 42:1900-5. 2003

Collaborators

Detail Information

Publications93

  1. ncbi request reprint Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: comparison with primary angioplasty and the role of distal protection devices (EMERALD trial)
    George Dangas
    Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY, USA
    Am Heart J 155:1090-6. 2008
    ..The value of distal protection devices during rescue PCI has not been studied...
  2. doi request reprint Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial)
    Kenichi Tsujita
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 105:1385-94. 2010
    ..Paradoxically, in this post hoc analysis, the reductions in major bleeding and mortality in ST elevation myocardial infarction afforded by bivalirudin occurred primarily in patients without baseline anemia...
  3. doi request reprint Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial)
    Kenji Goto
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 108:1387-94. 2011
    ..Bivalirudin monotherapy compared to UFH plus a GPI decreased major bleeding regardless of smoking status but may have different effects on individual components of ischemic events...
  4. ncbi request reprint Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model
    Nicholas N Kipshidze
    Department of Interventional Cardiac and Vascular Services, Lenox Hill Hospital, New York, NY 10021, USA
    Catheter Cardiovasc Interv 64:389-94. 2005
    ..001). In the porcine coronary model, site-specific systemic delivery of Rapamycin utilizing PGMC resulted in overexpression of p27 and a significant reduction of neointimal formation within the stented segments...
  5. doi request reprint Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial
    Gregg W Stone
    New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10022, USA
    Lancet 377:2193-204. 2011
    ..Primary results of the HORIZONS-AMI trial have been previously reported. In this final report, we aimed to assess 3-year outcomes...
  6. ncbi request reprint Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model
    Nicholas N Kipshidze
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
    Catheter Cardiovasc Interv 61:518-27. 2004
    ..In the porcine coronary model, an advanced c-myc-eluting PC stent blocked c-myc expression and significantly inhibited myointimal hyperplasia and allowed complete reendothelialization and healing response...
  7. doi request reprint Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes
    Usman Baber
    Mount Sinai Medical Center, New York, New York, USA
    JACC Cardiovasc Imaging 5:S53-61. 2012
    ..This study sought to evaluate the impact of chronic kidney disease (CKD) on coronary atherosclerotic plaque composition, morphology, and outcomes in patients with acute coronary syndromes (ACS)...
  8. doi request reprint Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial
    George Dangas
    Columbia University Medical Center, New York, New York Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 54:1438-46. 2009
    ....
  9. doi request reprint Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction
    Gregg W Stone
    Columbia University Medical Center and New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 360:1946-59. 2009
    ....
  10. ncbi request reprint Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 42:1900-5. 2003
    ..We sought to determine the impact of aggressive stent expansion on creatine kinase-MB isoenzyme (CK-MB) release and clinical restenosis...
  11. ncbi request reprint Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis
    Kazuyuki Shirai
    Cardiovascular Research Foundation, Lenox Hill Hospital, New York, New York 10022, USA
    Am J Cardiol 92:1409-13. 2003
    ..In matched lesions, beta and gamma VBT achieved similar reductions in treated segment restenosis and recurrent lesion length compared with placebo...
  12. ncbi request reprint Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era
    Tereza Pucelikova
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
    Am J Cardiol 101:63-8. 2008
    ..025). In conclusion, our data show that patients with SVG lesions remain a high-risk subgroup with worse outcomes after percutaneous coronary intervention compared with native vessel disease even in the era of drug-eluting stents...
  13. ncbi request reprint Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound
    Masashi Kimura
    The Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 98:436-42. 2006
    ..Although most ISAs after SES implantation do not resolve completely, the incidence of restenosis or thrombosis is not affected...
  14. ncbi request reprint Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaque
    Kenichi Fujii
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Am J Cardiol 95:355-9. 2005
    ..Plaque rupture morphology is associated with higher periprocedural CK-MB release and worse 1-year clinical outcome in patients treated with coronary stenting...
  15. ncbi request reprint Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection
    Dale T Ashby
    Lenox Hill Heart and Vascular Institute, New York, New York, USA
    J Am Coll Cardiol 41:749-52. 2003
    ..This study was designed to investigate the impact of percutaneous coronary interventions (PCIs) in degenerated saphenous vein grafts (SVGs) without distal embolic protection...
  16. doi request reprint The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale
    Roxana Mehran
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10032, USA
    Am Heart J 156:44-56. 2008
    ..Newer pharmacologic agents and drug-eluting stents may address both of these issues...
  17. doi request reprint Bivalirudin during primary PCI in acute myocardial infarction
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 358:2218-30. 2008
    ..The safety and efficacy of bivalirudin in high-risk patients are unknown...
  18. ncbi request reprint Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome
    Eduardo Missel
    Cardiovascular Research Foundation, Columbia University Medical Center, New York, NY, USA
    Am J Cardiol 101:573-8. 2008
    ..01) than patients with no predictors. In conclusion, VH-IVUS analysis showed that the percentage of NC and its ratio to DC in diseased coronary segments are positively associated with a high-risk ACS presentation...
  19. ncbi request reprint Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study
    Kenichi Fujii
    Cardiovascular Research Foundation, Columbia University Medical Center, 55 East 59th Street, New York, NY 10022, USA
    J Am Coll Cardiol 45:995-8. 2005
    ..We sought to determine the predictors of stent thrombosis after sirolimus-eluting stent (SES) implantation...
  20. ncbi request reprint The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention
    Adam J Saltzman
    Cardiovascular Medicine and the Center for Interventional Vascular Therapy, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY, 10032, USA
    J Invasive Cardiol 22:2-6. 2010
    ..We sought to compare the efficacy of tirofiban and abciximab on platelet inhibition as well as their effects of platelet inhibition on C-reactive protein levels during percutaneous coronary intervention (PCI)...
  21. doi request reprint Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial
    Philippe Genereux
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
    EuroIntervention 7:905-16. 2011
    ..There is a paucity of data comparing the TR approach with the TF approach in patients with STEMI treated with primary PCI and contemporary anticoagulant regimens...
  22. ncbi request reprint Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:1171-6. 2003
    ..Therefore, there does not appear to be any "downside" to aggressive stent implantation strategies in small vessels. In contrast, IVUS allows maximization of final lumen dimensions to minimize clinical restenosis...
  23. ncbi request reprint A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation
    Roxana Mehran
    Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York 10022, USA
    J Am Coll Cardiol 44:1393-9. 2004
    ..We sought to develop a simple risk score of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI)...
  24. ncbi request reprint Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III)
    Thosaphol Limpijankit
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 92:315-8. 2003
    ..e., drug-eluting stents) are available. Shorter time from brachytherapy to radiation failure and late thrombosis after brachytherapy were independent predictors of adverse events...
  25. ncbi request reprint Intravascular ultrasound study of patterns of calcium in ruptured coronary plaques
    Kenichi Fujii
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 96:352-7. 2005
    ..In conclusion, ruptured plaques are associated with a larger number of calcium deposits within an arc of <90 degrees , a larger number of deep calcium deposits, and a remodeling index...
  26. ncbi request reprint Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries
    Dale T Ashby
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascualr Institute, New York, New York 10022, USA
    Am J Cardiol 89:1162-6. 2002
    ..A stenting strategy for proximal LAD stenoses appears to attenuate the differences of clinical restenosis noted after non-stent PCI...
  27. ncbi request reprint Usefulness of the angiographic pattern of in-stent restenosis in predicting the success of gamma vascular brachytherapy
    Costantino O Costantini
    Cardiovascular Research Foundation, New York, New York 10021, USA
    Am J Cardiol 92:1214-7. 2003
    ....
  28. doi request reprint 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial
    Gregg W Stone
    Department of Medicine, Division of Cardiology, Columbia University, Medical Center New York Presbyterian Hospital, Cardiovascular Research Foundation, New York 10022, USA
    JACC Cardiovasc Interv 4:300-9. 2011
    ..We sought to evaluate the utility of the JOSTENT polytetrafluoroethylene (PTFE) stent-graft (Jomed GmbH, Rangendingen, Germany) in patients with diseased saphenous vein grafts (SVGs) undergoing percutaneous coronary intervention (PCI)...
  29. ncbi request reprint Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcome
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Am J Cardiol 93:963-8. 2004
    ..A less aggressive stent implantation strategy in SVGs than in native coronary lesions appears prudent...
  30. ncbi request reprint Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis
    Kenichi Fujii
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10021, USA
    Circulation 109:1085-8. 2004
    ..We used intravascular ultrasound (IVUS) to evaluate recurrence after sirolimus-eluting stent (SES) implantation treatment of in-stent restenosis (ISR)...
  31. ncbi request reprint Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach
    Eugenia Nikolsky
    Cardiovascular Research Foundation, Columbia University Medical Center, Herbert Irving Pavilion, 5th Floor, 161 Fort Washington Avenue, New York, NY 10032, USA
    Eur Heart J 28:1936-45. 2007
    ..Major bleeding after percutaneous coronary intervention (PCI) is an independent risk factor for early and late mortality. We developed and validated a risk score predictive of major bleeding after PCI using the femoral approach...
  32. ncbi request reprint Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%
    Makoto Hirose
    Cardiovascular Research Foundation, New York, NY 10021, USA
    Am J Cardiol 92:141-5. 2003
    ..7) were similar. Negative remodeling is frequently observed in lesions with intermediate stenosis. This suggests that negative remodeling occurs early in lesion formation...
  33. doi request reprint Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary gra
    Dinesh Kumar
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 106:941-5. 2010
    ....
  34. ncbi request reprint Effectiveness of the concomitant use of bivalirudin and drug-eluting stents (from the prospective, multicenter BivAlirudin and Drug-Eluting STents [ADEST] study)
    George Dangas
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 96:659-63. 2005
    ..Thus, use of bivalirudin as the procedural anticoagulant to support SES implantation in a "real world" population of patients undergoing PCI results in low rates of major adverse cardiac events, stent thrombosis, and major bleeding...
  35. ncbi request reprint Favorable effect of gamma-radiation for in-stent restenosis: effect of diabetes on angiographic and clinical outcomes
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Catheter Cardiovasc Interv 62:303-7. 2004
    ..DM remains a powerful predictor of TLR and major adverse cardiac events even after treatment of ISR with gamma-RT...
  36. ncbi request reprint Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials
    Somjot S Brar
    Columbia University Medical Center, New York, NY, USA
    EuroIntervention 5:475-84. 2009
    ....
  37. ncbi request reprint Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables
    George Dangas
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Am J Cardiol 95:13-9. 2005
    ..22 to 2.60). Thus, regardless of the presence of CKD, baseline characteristics and periprocedural hemodynamic parameters predict CIN, and this complication is associated with worse in-hospital and 1-year outcomes...
  38. ncbi request reprint Gamma radiation for in-stent restenosis: effect of lesion length on angiographic and clinical outcomes
    Roxana Mehran
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Catheter Cardiovasc Interv 61:354-9. 2004
    ..Lesion length remains a powerful predictor of recurrent ISR and clinical events after treatment of ISR even with gamma-RT...
  39. ncbi request reprint Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions
    Eugenia Nikolsky
    Cardiovascular Research Foundation, New York, New York, USA
    Kidney Int 67:706-13. 2005
    ..The relationship between low hematocrit and contrast-induced nephropathy has not been investigated...
  40. ncbi request reprint Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale
    Gregg W Stone
    Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
    Am Heart J 148:764-75. 2004
    ..Pilot trials suggest that the thrombin-specific anticoagulant bivalirudin may improve clinical outcomes in ACS...
  41. ncbi request reprint Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon
    Jose de Ribamar Costa
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 100:812-7. 2007
    ..In conclusion, in this observational, nonrandomized study, pretreatment with the AngioSculpt balloon enhanced stent expansion and minimized the difference between predicted and achieved stent dimensions...
  42. ncbi request reprint Female gender and mortality after percutaneous coronary intervention: results from a large registry
    Jason C Kovacic
    Cardiovascular Institute, Mount Sinai Medical Center, New York, New York 10029, USA
    Catheter Cardiovasc Interv 80:514-21. 2012
    ..To investigate if previously reported gender-based outcome disparities following percutaneous coronary intervention (PCI) are applicable in a large and racially-diverse cohort in the drug eluting stent (DES) era...
  43. ncbi request reprint Comparison of frequency of hemorrhagic stroke in patients <75 years versus > or =75 years of age among patients receiving glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 93:346-9. 2004
    ..5%) were aged > or =75 years (253 procedures, 430 lesions). Very elderly patients (> or =75 years) had similar in-hospital outcomes but a higher hemorrhagic stroke rate than patients aged <75 years...
  44. ncbi request reprint Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes
    Kenichi Fujii
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, 130 East 77th St, 9th Floor, New York, NY 10021, USA
    Circulation 108:2473-8. 2003
    ..It is not clear why some plaque ruptures lead to acute coronary syndromes (ACS) but others do not...
  45. ncbi request reprint Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or =80 years old versus those <80 years old
    Yoshio Kobayashi
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:443-6. 2003
    ....
  46. ncbi request reprint Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions
    Costantino O Costantini
    Cardiovascular Research Foundation, Lenox Hill Hospital, 55 East 59th Street, 6th Floor, New York, New York, NY 10022, USA
    J Am Coll Cardiol 41:1725-31. 2003
    ..We analyzed the effects of vascular brachytherapy (VBT) on ostial in-stent restenosis (ISR)...
  47. ncbi request reprint Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)
    Ricardo A Costa
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
    Am J Cardiol 95:113-6. 2005
    ..There was 1 in-stent and 1 in-segment (proximal edge) restenosis in the metallic stent group. There was no stent thrombosis or aneurysm formation at follow-up in either group...
  48. ncbi request reprint Dominant contribution of negative remodeling to development of significant coronary bifurcation narrowing
    Kenichi Fujii
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10021, USA
    Am J Cardiol 92:59-61. 2003
  49. ncbi request reprint Intravascular ultrasound assessment of fibrous cap remnants after coronary plaque rupture
    Lisette Okkels Jensen
    Cardiovascular Research Foundation, New York, NY 10022, USA
    Am Heart J 152:327-32. 2006
    ..Although intravascular ultrasound (IVUS) can detect plaque rupture, the fibrous cap remnant has not previously been studied in detail. The aim of the present study is to assess the fibrous cap remnants by IVUS in ruptured plaques...
  50. ncbi request reprint Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients >or=75 years of age versus those <75 years of age
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:1083-6. 2003
    ..5% were >or=75 years of age. Compared with patients <75 years old, those >or=75 years of age had similar procedural and in-hospital outcomes but significantly higher rates of hemorrhagic stroke (0.08% vs 1.2%, p <0.001)...
  51. pmc Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions
    Jason C Kovacic
    The Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY, United States
    Atherosclerosis 221:176-82. 2012
    ..We sought to explore this hypothesis in a large group of patients with coronary artery disease undergoing percutaneous coronary intervention (PCI)...
  52. ncbi request reprint Relation between the degree of procedural anticoagulation and complications after coronary stent implantation
    Dale T Ashby
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:319-22. 2003
    ..High levels of procedural anticoagulation with heparin were found to increase hemorrhagic complications without improving clinical or angiographic outcomes...
  53. ncbi request reprint Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials
    Jeffrey W Moses
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10032, USA
    J Am Coll Cardiol 47:2164-71. 2006
    ....
  54. ncbi request reprint Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention
    Ioannis Iakovou
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY, 10022, USA
    J Invasive Cardiol 15:18-22. 2003
    ..Contrast-induced nephropathy (CIN) is a recognized complication after percutaneous interventions (PCI). We sought to determine the impact of gender on incidence and clinical outcome of CIN...
  55. ncbi request reprint Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis
    Eugenia Nikolsky
    Cardiovascular Research Foundation and the Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 44:1200-9. 2004
    ..This study was designed to assess the safety of arteriotomy closure devices (ACDs) versus mechanical compression by meta-analysis in patients undergoing percutaneous transfemoral coronary procedures...
  56. doi request reprint Is accurate intravascular ultrasound evaluation of the left circumflex ostium from a left anterior descending to left main pullback possible?
    Carlos Oviedo
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 105:948-54. 2010
    ..For an accurate assessment of the side branch ostium, direct imaging is necessary...
  57. ncbi request reprint Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis
    Yoshio Kobayashi
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:1329-31. 2003
    ..02) but similar target vessel revascularization (35.1% vs 29.8%, p = 0.4) at follow-up...
  58. ncbi request reprint Vascular remodeling and plaque composition between focal and diffuse coronary lesions assessed by intravascular ultrasound
    Kenichi Fujii
    Cardiovascular Research Foundation, Columbia University Medical Center, New York, New York 10032, USA
    Am J Cardiol 94:1067-70. 2004
    ..Negative remodeling and fibrous and calcified plaque compositions contribute to stenosis development in diffuse lesions more frequently than in focal lesions...
  59. ncbi request reprint Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I
    Gregg W Stone
    Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
    Circulation 112:2364-72. 2005
  60. ncbi request reprint Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts
    Jose de Ribamar Costa
    Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 96:74-8. 2005
    ..These differences are independent of stent manufacturer, length, diameter, and deployment pressure...
  61. ncbi request reprint Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion
    Hideo Takebayashi
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Catheter Cardiovasc Interv 60:496-9. 2003
    ..This case report describes in-stent restenosis due to stent underexpansion after kissing stents using sirolimus-eluting stents...
  62. ncbi request reprint Successful use of the frontrunner catheter in the treatment of in-stent coronary chronic total occlusions
    Yi ming Yang
    Columbia University Medical Center and Cardiovascular Research Foundation, 161 Fort Washington Avenue, New York, NY 10032, USA
    Catheter Cardiovasc Interv 63:462-8. 2004
    ..TIMI 3 flow was achieved in all target vessels after further balloon angioplasty or stenting. The Frontrunner device is a safe and effective tool in the treatment of CTOs from ISR...
  63. doi request reprint Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: the Peripheral Arterial Disease in Interventional Patients Study
    Issam D Moussa
    Division of Cardiology, New York Presbyterian Hospital Weill Cornell Medical Center, Weill Medical College of Cornell University, New York, New York, USA
    Catheter Cardiovasc Interv 73:719-24. 2009
    ..Peripheral arterial disease (PAD) is under diagnosed in primary care practices, yet the extent of unrecognized PAD in patients with coronary artery disease (CAD) is unknown...
  64. ncbi request reprint Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteries
    Dale T Ashby
    Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY 10022, USA
    Am J Cardiol 91:979-81, A4, A7. 2003
  65. ncbi request reprint Percutaneous recanalization of chronically occluded coronary arteries: procedural techniques, devices, and results
    Gregg W Stone
    Division of Cardiology, Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    Catheter Cardiovasc Interv 66:217-36. 2005
  66. ncbi request reprint Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II
    Gregg W Stone
    Columbia University Medical Center, The Cardiovascular Research Foundation, New York, NY 10022, USA
    Circulation 112:2530-7. 2005
  67. ncbi request reprint Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions
    Eugenia Nikolsky
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
    Am J Cardiol 94:1023-7. 2004
    ..8% vs 3.5%). After adjustment for potential confounders, baseline hematocrit remained a significant predictor of a 1-year mortality rate (hazard ratio 0.93 per 1% increase in hematocrit, 95% confidence interval 0.91 to 0.95)...
  68. pmc Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agents
    Jorge Magallon
    Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA
    Circulation 123:319-26. 2011
    ..Here, we evaluate the use of this biological platform as a pharmacodynamic biomarker for antithrombotic therapies...
  69. ncbi request reprint Coronary artery spasm associated with a moderately severe atherosclerotic stenosis in the proximal LAD
    Dale T Ashby
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Invasive Cardiol 14:770-2. 2002
    ..We discuss the diagnostic value of intravascular ultrasound and treatment options for spasm associated with atherosclerotic plaques...
  70. ncbi request reprint Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery
    George Dangas
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    J Am Coll Cardiol 45:1186-92. 2005
    ..We sought to examine the efficacy of paclitaxel-eluting stent implantation in the left anterior descending coronary artery (LAD)...
  71. ncbi request reprint Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation
    Alexandra J Lansky
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 39:274-80. 2002
    ....
  72. ncbi request reprint Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)
    George Dangas
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 94:983-8. 2004
    ..The incidence of early thrombosis after primary angioplasty and stenting is decreased by abciximab use...
  73. ncbi request reprint Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 89:976-9. 2002
  74. ncbi request reprint PCI options in heparin-induced thrombocytopenia
    George Dangas
    Cardiovascular Research Foundation, Lenox Hill Heart Vascular Institute, New York, NY 10022, USA
    J Invasive Cardiol 15:622-3. 2003
  75. ncbi request reprint Acute angiographic and clinical results of the NIR w/SOX stent
    Yoshio Kobayashi
    Lenox Hill Heart and Vascular Institute, 130 East 77th Street, New York, NY 10021, USA
    J Invasive Cardiol 14:14-8. 2002
    ..Furthermore, it may have a high probability to be delivered in lesions where other kinds of stent result in unsuccessful delivery...
  76. ncbi request reprint Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysis
    Koichi Sano
    Cardiovascular Research Foundation, 611 Pennsylvania Avenue, S E, No 386, Washington, D C, USA
    J Invasive Cardiol 19:464-8. 2007
    ..The intravascular ultrasound (IVUS) findings during repeat intervention for drug-eluting stent (DES) restenosis have not been well described...
  77. ncbi request reprint Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model
    Nicholas N Kipshidze
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, 130 East 77th Street, Black Hall, 9th Floor, New York, NY 10021, USA
    Cardiovasc Radiat Med 4:152-9. 2003
    ..The purpose of this study was to investigate the effects of perfluorocarbon gas microbubble carrier (PGMC)-based systemic delivery of AVI-4126 on expression of the c-myc in vascular tissue and restenosis after stent implantation...
  78. ncbi request reprint Pulmonary hemorrhage during GP IIb/IIIa inhibitor therapy: an uncommon but life-threatening (and under-recognized) complication
    George Dangas
    Lenox Hill Heart and Vascular Institute, Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY 10022, USA
    J Invasive Cardiol 15:189-90. 2003
  79. ncbi request reprint Minimally invasive direct coronary artery bypass (MIDCAB) versus coronary artery stenting for elective revascularization of the left anterior descending artery
    Ioannis Iakovou
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 90:885-7. 2002
  80. ncbi request reprint Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model
    Nicholas N Kipshidze
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, New York 10021, USA
    J Am Coll Cardiol 39:1686-91. 2002
    ..We evaluated the long-term influence of intramural delivery of advanced c-myc neutrally charged antisense oligonucleotides (Resten-NG) on neointimal hyperplasia after stenting in a pig model...
  81. doi request reprint Intravascular ultrasound classification of plaque distribution in left main coronary artery bifurcations: where is the plaque really located?
    Carlos Oviedo
    Cardiovascular Research Foundation and Columbia University Medical Center, 111 East 59th Street, New York, NY 10022, USA
    Circ Cardiovasc Interv 3:105-12. 2010
    ..Angiographic classifications of the location and severity of disease in the main vessel and side branch of coronary artery bifurcations have been proposed and applied to distal left main coronary artery (LMCA) bifurcation...
  82. ncbi request reprint Complete vascular healing and sustained suppression of neointimal thickening after local delivery of advanced c-myc antisense at six months follow-up in a rabbit balloon injury model
    Nicholas Kipshidze
    Lenox Hill Heart and Vascular Institute and Cardiovascular Research Foundation, New York, NY 10021, USA
    Cardiovasc Radiat Med 3:26-30. 2002
    ..We evaluated the long-term impact of local delivery of c-myc neutrally charged antisense oligonucleotides (Resten-NG) upon neointimal formation following PTCA in a rabbit model...
  83. doi request reprint Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis
    Somjot S Brar
    Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, New York 10032, USA
    J Am Coll Cardiol 53:1677-89. 2009
    ..A secondary analysis was performed among registry studies...
  84. ncbi request reprint Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure
    Luis Gruberg
    Department of Cardiology, Rambam Medical Center, Haifa, Israel
    Catheter Cardiovasc Interv 55:66-72. 2002
    ..0001), and CRF (OR = 1.74; P = 0.003) were independent correlates of increased late mortality. Therefore, PCI in patients with impaired renal function, whether on dialysis or not, is associated with poor in-hospital and 1-year survival...
  85. ncbi request reprint Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting
    Deepak L Bhatt
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    J Am Coll Cardiol 39:9-14. 2002
    ..We sought to determine whether clopidogrel is at least as efficacious as ticlopidine...
  86. ncbi request reprint An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary intervention
    Eugenia Nikolsky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York City, NY 10022, USA
    J Invasive Cardiol 19:208-13. 2007
    ..We evaluated short-term prognosis and resource utilization of consecutive patients treated with percutaneous coronary intervention (PCI) as a function of fluoroscopy time...
  87. doi request reprint Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention
    Emilia Solinas
    Division of Cardiology, Parma University Hospital, Italy
    Am J Cardiol 102:311-5. 2008
    ..Treatment with either repeated DES implantation or balloon angioplasty for DES-ISR was safe and associated with low overall rates of target-lesion revascularization and major adverse cardiac events at 1 year...
  88. ncbi request reprint Interventional therapy for acute myocardial infarction: respect the microvasculature
    George Dangas
    J Am Coll Cardiol 42:1403-5. 2003
  89. doi request reprint Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials
    Stuart J Pocock
    London School of Hygiene and Tropical Medicine, London, United Kingdom
    J Am Coll Cardiol 51:23-32. 2008
    ..We sought to validate 4 angiographic measures as potential surrogates for clinical restenosis (target lesion revascularization [TLR]) after stent implantation...
  90. ncbi request reprint Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy)
    Paul S Teirstein
    Scripps Clinic, La Jolla, California, USA
    Am J Cardiol 96:500-5. 2005
    ..By multivariate analysis, use of GP IIb/IIIa inhibitors during stenting with the TAXUS stent was an independent predictor of CK-MB increases >3 times the normal level. Further studies are warranted...
  91. ncbi request reprint Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction
    Gregg W Stone
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 39:591-7. 2002
    ..We sought to evaluate and validate the ability of the angiographic myocardial blush grade to risk stratify patients after successful angioplasty in acute myocardial infarction (AMI)...
  92. ncbi request reprint Clopidogrel loading dose pre-PCI: how high?
    Eugenia Nikolsky
    J Invasive Cardiol 16:551-2. 2004
  93. ncbi request reprint Editorial commentary: in-stent restenosis and cutting balloon
    George Dangas
    J Invasive Cardiol 14:297-8. 2002